Charles River Laboratories Inte · Diagnostics & Research
CRLCharles River Laboratories Inte
No earnings date on file for this stock yet.
Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →
Charles River Laboratories Inte earnings preview: what the record says
Across its last 8 reports, CRL beat the EPS consensus 8 times out of 8 with a figure on file, and the stock moved an average of 8.3% on the first trading day, closing higher 4 of 8 times. That first-day move was larger than the options-implied move in 5 of 8 reports. Measured over five sessions, the average move was 11.8%.
Historically, CRL has tended to move more than its options implied. A beat alone has not been enough: CRL closed higher after only 4 of its 8 EPS beats. NextPick tracks CRL in its Life Sciences Tools basket alongside TMO, DHR, A and WAT, whose prints read through to this one.
Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.
CRL earnings: key questions
How much does CRL stock move after earnings?
Over its last 8 reports, CRL moved an average of 8.3% on the first trading day after earnings. The move was larger than the options-implied move in 5 of 8 reports.
Does CRL usually beat earnings estimates?
CRL beat the EPS consensus in 8 of its last 8 reports with a surprise on file and missed in 0.